MIR3147HG: A Potential Drug Target and Biomarker (G100653233)
MIR3147HG: A Potential Drug Target and Biomarker
Mir3147HG, a synthetic peptide derived from the N-terminal region of the melatonin receptor 2 (MTOR), has been identified as a potential drug target and biomarker for various psychiatric and neurological disorders. TheMTOR, also known as the melatonin receptor, is a G protein-coupled receptor that plays a crucial role in regulating sleep-wake cycles and other physiological processes that are synchronized with darkness-inducing signals. MIR3147HG has been shown to interact with the MTOR and modulate its activity, making it a promising candidate for drug development.
In recent years, the use of peptides derived from G protein-coupled receptors (GPCRs) has become an increasingly popular approach for drug discovery. GPCRs are a family of transmembrane proteins that play a central role in many physiological processes, including sensory perception, neurotransmission, and hormone regulation. They are involved in a wide range of diseases, including anxiety, depression, and neurodegenerative disorders. Therefore, the development of new GPCR-derived drugs with unique properties and pharmacological profiles is a promising strategy for the development of new treatments.
MIR3147HG was identified as a potential drug target and biomarker by its ability to interact with the MTOR. The MTOR is a GPCR that is expressed in many tissues and is involved in the regulation of various physiological processes, including sleep-wake cycles, hormone regulation, and neurotransmission. MIR3147HG has been shown to activate the MTOR and increase its activity, which could potentially lead to the regulation of sleep-wake cycles and other physiological processes that are synchronized with darkness-inducing signals.
In addition to its potential therapeutic applications, MIR3147HG also has the potential to serve as a biomarker for certain psychiatric and neurological disorders. The MTOR is involved in the regulation of various psychiatric and neurological symptoms, including anxiety, depression, and neurodegenerative disorders. Therefore, the modulation of MTOR activity by MIR3147HG could potentially provide valuable information for the diagnosis and treatment of these disorders.
In conclusion, MIR3147HG is a promising candidate for drug development as a potential drug target and biomarker for various psychiatric and neurological disorders. Its ability to interact with the MTOR and modulate its activity makes it a promising target for small molecules that can be used to treat a wide range of psychiatric and neurological disorders. Further studies are needed to confirm its potential and develop safe and effective drugs that target MIR3147HG.
Protein Name: MIR3147 Host Gene
The "MIR3147HG Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR3147HG comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR3148 | MIR3149 | MIR3150A | MIR3150B | MIR3151 | MIR3152 | MIR3153 | MIR3154 | MIR3155A | MIR3155B | MIR3156-1 | MIR3156-2 | MIR3156-3 | MIR3157 | MIR3158-1 | MIR3158-2 | MIR3159 | MIR3160-1 | MIR3160-2 | MIR3161 | MIR3162 | MIR3163 | MIR3164 | MIR3165 | MIR3166 | MIR3167 | MIR3168 | MIR3169 | MIR3170 | MIR3171 | MIR3171HG | MIR3173 | MIR3174 | MIR3175 | MIR3176 | MIR3177 | MIR3178 | MIR3179-1 | MIR3179-2 | MIR3179-3 | MIR3180-1 | MIR3180-2 | MIR3180-3 | MIR3180-4 | MIR3180-5 | MIR3182 | MIR3183 | MIR3184 | MIR3185 | MIR3186 | MIR3187 | MIR3188 | MIR3189 | MIR3190 | MIR3191 | MIR3192 | MIR3193 | MIR3194 | MIR3195 | MIR3196 | MIR3197 | MIR3198-1 | MIR3199-1 | MIR3199-2 | MIR31HG | MIR32 | MIR3200 | MIR3201 | MIR3202-1 | MIR3202-2 | MIR320A | MIR320B1 | MIR320B2 | MIR320C1 | MIR320C2 | MIR320D1 | MIR320D2 | MIR320E | MIR323A | MIR323B | MIR324 | MIR325 | MIR325HG | MIR326 | MIR328 | MIR329-1 | MIR329-2 | MIR330 | MIR331 | MIR335 | MIR337 | MIR338 | MIR339 | MIR33A | MIR33B | MIR340 | MIR342 | MIR345 | MIR346 | MIR34A
